Literature DB >> 12153831

Information processing deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission.

William Perry1, David Feifel, Arpi Minassian, Indira Bhattacharjie, David L Braff.   

Abstract

OBJECTIVE: In patients with schizophrenia, information processing deficits, such as those reported in studies that measured prepulse inhibition of the human startle response and habituation of startle magnitude, may be improved with atypical antipsychotic treatment. However, it remains unclear whether antipsychotic medication is directly responsible for the improvement or whether differences in prepulse inhibition reflect other factors, such as acuity status. The present study investigated the effects of antipsychotics on prepulse inhibition and startle habituation in acutely hospitalized patients with schizophrenia.
METHOD: Forty-one acutely psychotic schizophrenia patients (21 who were unmedicated at the time of admission and 20 who had been receiving antipsychotic treatment) were tested within 72 hours of hospital admission. Thirteen healthy subjects were also studied for comparative purposes. Primary dependent measures were startle responsivity, reactivity, prepulse inhibition, and startle habituation.
RESULTS: Schizophrenia patients, whether medicated or unmedicated at admission, showed prepulse inhibition deficits compared with healthy subjects and did not statistically differ from each other in startle magnitude, prepulse inhibition, or habituation. There was a higher number of startle "nonresponders" among those who had been receiving medication versus those unmedicated at the time of admission.
CONCLUSIONS: The present findings suggest that antipsychotic effects on prepulse inhibition may not be evident at a time when schizophrenia patients are acutely symptomatic. These results suggest that the neurobiological substrate underlying prepulse inhibition deficits may be dysregulated during acute psychotic states while the patients are in early phases of medication treatment.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12153831     DOI: 10.1176/appi.ajp.159.8.1375

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  22 in total

Review 1.  Endophenotypes in schizophrenia: a selective review.

Authors:  Allyssa J Allen; Mélina E Griss; Bradley S Folley; Keith A Hawkins; Godfrey D Pearlson
Journal:  Schizophr Res       Date:  2009-02-15       Impact factor: 4.939

2.  Prepulse inhibition of startle in adults with ADHD.

Authors:  David Feifel; Arpi Minassian; William Perry
Journal:  J Psychiatr Res       Date:  2008-07-31       Impact factor: 4.791

3.  Effects of dopamine D2/D3 blockade on human sensory and sensorimotor gating in initially antipsychotic-naive, first-episode schizophrenia patients.

Authors:  Signe Düring; Birte Y Glenthøj; Gitte Saltoft Andersen; Bob Oranje
Journal:  Neuropsychopharmacology       Date:  2014-07-23       Impact factor: 7.853

4.  Neonatal exposure to phenobarbital potentiates schizophrenia-like behavioral outcomes in the rat.

Authors:  S K Bhardwaj; P A Forcelli; G Palchik; K Gale; L K Srivastava; A Kondratyev
Journal:  Neuropharmacology       Date:  2012-02-15       Impact factor: 5.250

5.  Heritability of acoustic startle magnitude, prepulse inhibition, and startle latency in schizophrenia and control families.

Authors:  Wendy Hasenkamp; Michael P Epstein; Amanda Green; Lisette Wilcox; William Boshoven; Barbara Lewison; Erica Duncan
Journal:  Psychiatry Res       Date:  2010-05-16       Impact factor: 3.222

6.  Meta-Analysis of Sensorimotor Gating Deficits in Patients With Schizophrenia Evaluated by Prepulse Inhibition Test.

Authors:  Rodrigo San-Martin; Leonardo Andrade Castro; Paulo Rossi Menezes; Francisco José Fraga; Priscyla Waleska Simões; Cristiane Salum
Journal:  Schizophr Bull       Date:  2020-12-01       Impact factor: 9.306

7.  Sensorimotor gating is associated with CHRNA3 polymorphisms in schizophrenia and healthy volunteers.

Authors:  Nadine Petrovsky; Boris B Quednow; Ulrich Ettinger; Anne Schmechtig; Rainald Mössner; David A Collier; Kai-Uwe Kühn; Wolfgang Maier; Michael Wagner; Veena Kumari
Journal:  Neuropsychopharmacology       Date:  2010-03-10       Impact factor: 7.853

8.  Heritability of acoustic startle magnitude and latency from the consortium on the genetics of schizophrenia.

Authors:  Tiffany A Greenwood; Neal R Swerdlow; Joyce Sprock; Monica E Calkins; Robert Freedman; Michael F Green; Raquel E Gur; Ruben C Gur; Laura C Lazzeroni; Gregory A Light; Keith H Nuechterlein; Allen D Radant; Jeremy M Silverman; William S Stone; Catherine A Sugar; Debby W Tsuang; Ming T Tsuang; Bruce I Turetsky; David L Braff; Erica Duncan
Journal:  Schizophr Res       Date:  2020-11-12       Impact factor: 4.939

Review 9.  Realistic expectations of prepulse inhibition in translational models for schizophrenia research.

Authors:  Neal R Swerdlow; Martin Weber; Ying Qu; Gregory A Light; David L Braff
Journal:  Psychopharmacology (Berl)       Date:  2008-06-21       Impact factor: 4.530

Review 10.  Cognitive dysfunction in chronic hepatitis C: a review.

Authors:  William Perry; Robin C Hilsabeck; Tarek I Hassanein
Journal:  Dig Dis Sci       Date:  2007-08-17       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.